Evidence supporting the use of: Vitamin E (tocopherol not specified)
For the health condition: Cataracts

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E has been investigated for its potential role in preventing or slowing the progression of cataracts, primarily due to its antioxidant properties. Cataracts are believed to develop partly because of oxidative damage to lens proteins and lipids over time. Vitamin E, as a lipid-soluble antioxidant, can neutralize reactive oxygen species and may theoretically protect lens cells from such damage.

Epidemiological studies have produced mixed results. Some observational studies suggest that higher dietary intake or blood levels of vitamin E are associated with a reduced risk of cataract formation. However, randomized controlled trials (RCTs) have generally not demonstrated a significant benefit of vitamin E supplementation in either preventing cataracts or slowing their progression. For example, the Age-Related Eye Disease Study (AREDS), a large RCT, found no significant effect of vitamin E on the development or progression of cataracts.

Therefore, while vitamin E is used based on its plausible biological mechanisms and some population-based evidence, the overall scientific support—especially from high-quality clinical trials—is weak. Most clinical guidelines do not recommend vitamin E supplementation specifically for cataract prevention or treatment. Its use is thus justified by limited scientific rationale but not robust clinical evidence.

More about Vitamin E (tocopherol not specified)
More about Cataracts

Products containing Vitamin E (tocopherol not specified)

We currently have no products on Vitabase that contain this ingredient.